Zhejiang Xianju PharmaceuticalLtd Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Weihua Jin

Algemeen directeur

CN¥1.2m

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	1.9yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	7.9yrs
Gemiddelde ambtstermijn bestuur	3.5yrs

Recente managementupdates

Recent updates

CEO

Weihua Jin (49 yo)

1.9yrs

Tenure

CN¥1,226,700

Compensatie

Mr. Weihua Jin serves as Non-Independent Director at Zhejiang Xianju Pharmaceutical Co.,Ltd. since December 23, 2022. He was Deputy General Manager of Zhejiang Xianju Pharmaceutical Co.,Ltd.from November...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Weihua Jin	GM & Director	no data	CN¥1.23m	geen gegevens
Yao Hua Wang	CFO, Financial Director & Chief Accountant	11.5yrs	CN¥940.20k	geen gegevens
Wangwei Zhang	Deputy GM	7.9yrs	CN¥758.00k	geen gegevens
Carlo Cartasegna	Deputy General Manager	6.9yrs	CN¥918.10k	geen gegevens

7.9yrs

Gemiddelde duur

51yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 002332 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.9 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Weihua Jin	GM & Director	1.9yrs	CN¥1.23m	geen gegevens
Wangwei Zhang	Deputy GM	7.9yrs	CN¥758.00k	geen gegevens
Chi Zhang	Member of Supervisory Board	10.9yrs	geen gegevens	geen gegevens
Yusong Zhang	Chairman	no data	CN¥1.45m	geen gegevens
Weiwu Chen	Non-Independent Director	1.9yrs	geen gegevens	geen gegevens
Guo Jun Zhang	Director	16.9yrs	geen gegevens	geen gegevens
Hongying Zhang	Independent Director	4.9yrs	CN¥72.00k	geen gegevens
Yanqin Li	Supervisor	4.9yrs	geen gegevens	geen gegevens
Baohu Cao	Non-Independent Director	1.9yrs	geen gegevens	geen gegevens
Yunhong Hao	Independent director	3.5yrs	CN¥72.00k	geen gegevens
Bin Liu	Independent Director	1.9yrs	CN¥72.00k	geen gegevens
Tianfei Wu	Chairman of the Supervisory Board	1.9yrs	geen gegevens	geen gegevens

3.5yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 002332 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).

Zhejiang Xianju PharmaceuticalLtd Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Zhejiang Xianju Pharmaceutical Co.,Ltd., Annual General Meeting, May 21, 2024

High number of new directors

Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Management Elections

Less than half of directors are independent

Insufficient new directors

Zhejiang Xianju Pharmaceutical Co.,Ltd., Annual General Meeting, May 12, 2022

Recent updates

Investor sentiment improves as stock rises 17%

Zhejiang Xianju Pharmaceutical Co.,Ltd. to Report Q3, 2024 Results on Oct 26, 2024

Zhejiang Xianju Pharmaceutical Co.,Ltd. to Report First Half, 2024 Results on Aug 27, 2024

Dividend of CN¥0.30 announced

Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces 2023 Final Profit Distribution on A Shares, Payable on 05 June 2024

Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Final Dividend for the Year 2023

First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.13 in 1Q 2023)

Zhejiang Xianju Pharmaceutical Co.,Ltd., Annual General Meeting, May 21, 2024

Zhejiang Xianju Pharmaceutical Co.,Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Investor sentiment improves as stock rises 18%

Zhejiang Xianju Pharmaceutical Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Investor sentiment improves as stock rises 17%

New minor risk - Share price stability

Zhejiang Xianju Pharmaceutical Co.,Ltd. to Report Q3, 2023 Results on Oct 26, 2023

Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023

First quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.17 in 1Q 2022)

Full year 2022 earnings released: EPS: CN¥0.75 (vs CN¥0.62 in FY 2021)

High number of new directors

Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Management Elections

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.18 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.17 in 2Q 2021)

Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 8, 2022

Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves 2021 Profit Distribution Plan At the Annual General Meeting Held on May 12, 2022

Insufficient new directors

Zhejiang Xianju Pharmaceutical Co.,Ltd., Annual General Meeting, May 12, 2022

Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Cash Dividend for 2021

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.17 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.15 in 2Q 2020)

Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces 2020 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 04 June 2021

Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2020

First quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.07 in 1Q 2020)

Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces Final Profit Distribution Proposal for 2020

Investor sentiment improved over the past week

New 90-day low: CN¥11.50

New 90-day low: CN¥12.45

New 90-day low: CN¥13.10

New 90-day low: CN¥14.04

Third quarter earnings released

First half earnings released

Zhejiang Xianju Pharmaceutical Co.,Ltd. to Report First Half, 2020 Results on Aug 28, 2020

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd